RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Clinical Laserthermia Systems Stock

Clinical Laserthermia Systems Liabilities 2024

Clinical Laserthermia Systems Liabilities

11.96 M SEK

Ticker

CLS B.ST

ISIN

SE0002756130

WKN

A12CNJ

In 2024, Clinical Laserthermia Systems's total liabilities amounted to 11.96 M SEK, a -70.32% difference from the 40.29 M SEK total liabilities in the previous year.

Clinical Laserthermia Systems Aktienanalyse

What does Clinical Laserthermia Systems do?

Clinical Laserthermia Systems AB (CLS) is a Swedish company that specializes in the development, production, and marketing of medical laser devices. The company was founded in 2008 and is headquartered in Lund, Sweden. CLS's history began with the development of a new method for treating cancer using laser beams. The founders of the company recognized the limited options of conventional tumor treatment methods and decided to develop an innovative technology based on a non-invasive, minimally invasive method of destroying cancer cells using laser beams. CLS's business model is based on the development, production, and marketing of medical laser devices for the treatment of cancer. CLS's products include various types of laser devices for the treatment of tumors in different parts of the body such as the prostate, breast, liver, lung, and other soft tissue tumors. The company also offers training and education for the use of the devices, as well as comprehensive technical support for doctors and medical professionals who use these devices. CLS has various divisions, including the urology division for the treatment of prostate cancer and the tumor division for the treatment of tumors in other parts of the body such as the breast, liver, and lung. CLS's flagship product is the TRANBERG®|Thermal Therapy System. It is an advanced laser device that allows for precise and targeted treatment of tumors by using laser beams to destroy cancer cells while protecting the surrounding tissue and organs. The TRANBERG®|Thermal Therapy System works through a technique called interstitial laser thermotherapy, where laser beams are delivered directly into the tumor through specially designed catheters. The radiation effect leads to the heating of the cancer tissue and ultimately its destruction, while the surrounding tissue remains largely unaffected. CLS's product portfolio also includes the TRANBERG®|Laser Light as an equivalent alternative to traditional tumor surgery. This is an established system that is used in both the diagnosis and treatment of prostate cancer. CLS's target market includes both public and private medical institutions worldwide. The company focuses on markets in Europe, Asia, and North America. In order to meet this goal, the company is present at international conferences and trade fairs and collaborates with global partners and distributors. CLS aims to improve cancer treatment worldwide by developing innovative technologies and solutions that enable more precise, effective, and less invasive treatment of tumors. The company has a clear vision: "To improve lives for cancer patients by making the treatment simpler, more effective, and less invasive." Clinical Laserthermia Systems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Clinical Laserthermia Systems's Liabilities

Clinical Laserthermia Systems's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Clinical Laserthermia Systems's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Clinical Laserthermia Systems's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Clinical Laserthermia Systems's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Clinical Laserthermia Systems’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Clinical Laserthermia Systems stock

What is the level of liabilities of Clinical Laserthermia Systems this year?

Clinical Laserthermia Systems has a debt balance of 11.96 M SEK this year.

What were the liabilities of Clinical Laserthermia Systems compared to the previous year?

The liabilities of Clinical Laserthermia Systems have increased by -70.32% dropped compared to the previous year.

What are the consequences of high debt for investors of Clinical Laserthermia Systems?

High liabilities can pose a risk for investors of Clinical Laserthermia Systems, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Clinical Laserthermia Systems?

Low liabilities mean that Clinical Laserthermia Systems has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Clinical Laserthermia Systems affect the company?

An increase in liabilities of Clinical Laserthermia Systems can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Clinical Laserthermia Systems affect the company?

A decrease in the liabilities of Clinical Laserthermia Systems can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Clinical Laserthermia Systems?

Some factors that can influence the liabilities of Clinical Laserthermia Systems include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Clinical Laserthermia Systems so important for investors?

The liabilities of Clinical Laserthermia Systems are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Clinical Laserthermia Systems take to modify the liabilities?

To change its liabilities, Clinical Laserthermia Systems can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Clinical Laserthermia Systems pay?

Over the past 12 months, Clinical Laserthermia Systems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clinical Laserthermia Systems is expected to pay a dividend of 0 SEK.

What is the dividend yield of Clinical Laserthermia Systems?

The current dividend yield of Clinical Laserthermia Systems is .

When does Clinical Laserthermia Systems pay dividends?

Clinical Laserthermia Systems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Clinical Laserthermia Systems?

Clinical Laserthermia Systems paid dividends every year for the past 0 years.

What is the dividend of Clinical Laserthermia Systems?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Clinical Laserthermia Systems located?

Clinical Laserthermia Systems is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clinical Laserthermia Systems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clinical Laserthermia Systems from 11/29/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/29/2024.

When did Clinical Laserthermia Systems pay the last dividend?

The last dividend was paid out on 11/29/2024.

What was the dividend of Clinical Laserthermia Systems in the year 2023?

In the year 2023, Clinical Laserthermia Systems distributed 0 SEK as dividends.

In which currency does Clinical Laserthermia Systems pay out the dividend?

The dividends of Clinical Laserthermia Systems are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Clinical Laserthermia Systems

Our stock analysis for Clinical Laserthermia Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clinical Laserthermia Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.